• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬抑制剂Spautin-1通过一种不依赖自噬且由USP13介导的机制拮抗突变型囊性纤维化跨膜传导调节因子(CFTR)的挽救作用。

The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism.

作者信息

Pesce Emanuela, Sondo Elvira, Ferrera Loretta, Tomati Valeria, Caci Emanuela, Scudieri Paolo, Musante Ilaria, Renda Mario, Baatallah Nesrine, Servel Nathalie, Hinzpeter Alexandre, di Bernardo Diego, Pedemonte Nicoletta, Galietta Luis J V

机构信息

U.O.C. Genetica Medica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.

出版信息

Front Pharmacol. 2018 Dec 13;9:1464. doi: 10.3389/fphar.2018.01464. eCollection 2018.

DOI:10.3389/fphar.2018.01464
PMID:30618756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6300570/
Abstract

The mutation F508del, responsible for a majority of cystic fibrosis cases, provokes the instability and misfolding of the CFTR chloride channel. Pharmacological recovery of F508del-CFTR may be obtained with small molecules called correctors. However, treatment with a single corrector and only leads to a partial rescue, a consequence of cell quality control systems that still detect F508del-CFTR as a defective protein causing its degradation. We tested the effect of spautin-1 on F508del-CFTR since it is an inhibitor of USP10 deubiquitinase and of autophagy, a target and a biological process that have been associated with cystic fibrosis and mutant CFTR. We found that short-term treatment of cells with spautin-1 downregulates the function and expression of F508del-CFTR despite the presence of corrector VX-809, a finding obtained in multiple cell models and assays. In contrast, spautin-1 was ineffective on wild type CFTR. Silencing and upregulation of USP13 (another target of spautin-1) but not of USP10, had opposite effects on F508del-CFTR expression/function. In contrast, modulation of autophagy with known activators or inhibitors did not affect F508del-CFTR. Our results identify spautin-1 as a novel chemical probe to investigate the molecular mechanisms that prevent full rescue of mutant CFTR.

摘要

导致大多数囊性纤维化病例的F508del突变会引发CFTR氯离子通道的不稳定和错误折叠。使用称为校正剂的小分子可以实现F508del-CFTR的药理学恢复。然而,单一校正剂治疗仅能带来部分挽救效果,这是由于细胞质量控制系统仍将F508del-CFTR检测为有缺陷的蛋白质并导致其降解。我们测试了spautin-1对F508del-CFTR的影响,因为它是USP10去泛素酶和自噬的抑制剂,而自噬是一个与囊性纤维化和突变型CFTR相关的靶点和生物学过程。我们发现,尽管存在校正剂VX-809,但用spautin-1对细胞进行短期处理会下调F508del-CFTR的功能和表达,这一发现在多个细胞模型和实验中均得到证实。相比之下,spautin-1对野生型CFTR无效。USP13(spautin-1的另一个靶点)的沉默和上调而非USP10,对F508del-CFTR的表达/功能有相反的影响。相比之下,用已知的自噬激活剂或抑制剂调节自噬并不影响F508del-CFTR。我们的研究结果确定spautin-1是一种新型化学探针,可用于研究阻止突变型CFTR完全挽救的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997b/6300570/562560cc8aa0/fphar-09-01464-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997b/6300570/7f0692580016/fphar-09-01464-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997b/6300570/562560cc8aa0/fphar-09-01464-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997b/6300570/7f0692580016/fphar-09-01464-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997b/6300570/562560cc8aa0/fphar-09-01464-g007.jpg

相似文献

1
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism.自噬抑制剂Spautin-1通过一种不依赖自噬且由USP13介导的机制拮抗突变型囊性纤维化跨膜传导调节因子(CFTR)的挽救作用。
Front Pharmacol. 2018 Dec 13;9:1464. doi: 10.3389/fphar.2018.01464. eCollection 2018.
2
Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.解析突变 F508del-CFTR 更易受四种囊性纤维化校正剂作用的区域。
Int J Mol Sci. 2019 Nov 1;20(21):5463. doi: 10.3390/ijms20215463.
3
The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation.导致囊性纤维化的主要突变表现出磷酸化倾向缺陷。
Proteomics. 2015 Jan;15(2-3):447-61. doi: 10.1002/pmic.201400218. Epub 2014 Dec 17.
4
Searching for combinations of small-molecule correctors to restore f508del-cystic fibrosis transmembrane conductance regulator function and processing.寻找小分子校正剂的组合以恢复F508del-囊性纤维化跨膜传导调节因子的功能和加工过程。
J Pharmacol Exp Ther. 2014 Sep;350(3):624-34. doi: 10.1124/jpet.114.214890. Epub 2014 Jun 26.
5
A chemical corrector modifies the channel function of F508del-CFTR.一种化学纠偏剂可改变 F508del-CFTR 的通道功能。
Mol Pharmacol. 2010 Sep;78(3):411-8. doi: 10.1124/mol.110.065862. Epub 2010 May 25.
6
Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel.发现一种皮摩尔效力的突变 CFTR 氯离子通道药理学矫正剂。
Sci Adv. 2020 Feb 21;6(8):eaay9669. doi: 10.1126/sciadv.aay9669. eCollection 2020 Feb.
7
Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622.通过甘氨酸622突变揭示蛋白酶体依赖性对囊性纤维化跨膜传导调节因子的药理学挽救作用。
J Pharmacol Exp Ther. 2008 Apr;325(1):89-99. doi: 10.1124/jpet.107.134502. Epub 2008 Jan 29.
8
Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays.基于VX-809的杂合衍生物向类药物F508del-CFTR校正剂的研发历程:从分子建模到化学合成及生物学测定
Pharmaceuticals (Basel). 2022 Feb 23;15(3):274. doi: 10.3390/ph15030274.
9
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.增加囊性纤维化跨膜传导调节因子F508del等位基因的内质网储备可导致小分子疗法对其进行更大程度的折叠校正。
PLoS One. 2016 Oct 12;11(10):e0163615. doi: 10.1371/journal.pone.0163615. eCollection 2016.
10
Treatment of Polarized Cystic Fibrosis Airway Cells With HGF Prevents VX-661-Rescued F508del-CFTR Destabilization Caused by Prolonged Co-exposure to VX-770.用肝细胞生长因子处理极化的囊性纤维化气道细胞可防止因长期共同暴露于VX-770而导致的VX-661挽救的F508del-CFTR蛋白不稳定。
Front Mol Biosci. 2021 Dec 22;8:812101. doi: 10.3389/fmolb.2021.812101. eCollection 2021.

引用本文的文献

1
Interplay between ALK2 mutant receptor and autophagy signaling regulates receptor stability and its chondrogenic functions.ALK2 突变受体与自噬信号之间的相互作用调节受体稳定性及其软骨形成功能。
Cell Death Discov. 2025 Mar 22;11(1):117. doi: 10.1038/s41420-025-02393-0.
2
Esc peptides and derivatives potentiate the activity of CFTR with gating defects and display antipseudomonal activity in cystic fibrosis-like lung disease.Esc肽及其衍生物可增强具有门控缺陷的囊性纤维化跨膜传导调节因子(CFTR)的活性,并在类囊性纤维化肺病中表现出抗铜绿假单胞菌活性。
Cell Mol Life Sci. 2025 Mar 18;82(1):121. doi: 10.1007/s00018-025-05633-9.
3
Autophagy and the peroxisome proliferator-activated receptor signaling pathway: A molecular ballet in lipid metabolism and homeostasis.

本文引用的文献

1
Noncanonical autophagy at ER exit sites regulates procollagen turnover.内质网出口位点的非典型自噬调节原胶原的周转。
Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10099-E10108. doi: 10.1073/pnas.1814552115. Epub 2018 Oct 4.
2
Specific autophagy and ESCRT components participate in the unconventional secretion of CFTR.特定的自噬和 ESCRT 成分参与 CFTR 的非经典分泌。
Autophagy. 2018;14(10):1761-1778. doi: 10.1080/15548627.2018.1489479. Epub 2018 Jul 31.
3
High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel.
自噬与过氧化物酶体增殖物激活受体信号通路:脂质代谢与体内平衡中的分子芭蕾。
Mol Cell Biochem. 2025 Jun;480(6):3477-3499. doi: 10.1007/s11010-025-05207-0. Epub 2025 Feb 1.
4
Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?自噬靶向作为酪氨酸激酶抑制剂联合应用的有效辅助策略是否可行?
Cancers (Basel). 2024 Aug 28;16(17):2989. doi: 10.3390/cancers16172989.
5
Targeting ubiquitination machinery in cystic fibrosis: Where do we stand?靶向囊性纤维化中的泛素化机制:我们处于什么位置?
Cell Mol Life Sci. 2024 Jun 18;81(1):271. doi: 10.1007/s00018-024-05295-z.
6
Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases.靶向铁死亡和铁蛋白自噬:心血管疾病的新靶点。
J Zhejiang Univ Sci B. 2024 Jan 15;25(1):1-22. doi: 10.1631/jzus.B2300097.
7
Tryptophan mutations in G3BP1 tune the stability of a cellular signaling hub by weakening transient interactions with Caprin1 and USP10.G3BP1 中的色氨酸突变通过削弱与 Caprin1 和 USP10 的瞬时相互作用来调节细胞信号枢纽的稳定性。
J Biol Chem. 2022 Dec;298(12):102552. doi: 10.1016/j.jbc.2022.102552. Epub 2022 Sep 29.
8
Research Progress of DUB Enzyme in Hepatocellular Carcinoma.去泛素化酶在肝细胞癌中的研究进展
Front Oncol. 2022 Jun 27;12:920287. doi: 10.3389/fonc.2022.920287. eCollection 2022.
9
USP10 as a Potential Therapeutic Target in Human Cancers.USP10 作为人类癌症的潜在治疗靶点。
Genes (Basel). 2022 May 6;13(5):831. doi: 10.3390/genes13050831.
10
Identification of Dysregulated Mechanisms and Candidate Gene Markers in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中失调机制和候选基因标志物的鉴定。
Int J Chron Obstruct Pulmon Dis. 2022 Mar 4;17:475-487. doi: 10.2147/COPD.S349694. eCollection 2022.
高通量筛选鉴定 FAU 蛋白为突变型囊性纤维化跨膜电导调节子通道的调节剂。
J Biol Chem. 2018 Jan 26;293(4):1203-1217. doi: 10.1074/jbc.M117.816595. Epub 2017 Nov 20.
4
USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response.USP13 调节 RAP80-BRCA1 复合物依赖的 DNA 损伤反应。
Nat Commun. 2017 Jun 1;8:15752. doi: 10.1038/ncomms15752.
5
Direct Binding of the Corrector VX-809 to Human CFTR NBD1: Evidence of an Allosteric Coupling between the Binding Site and the NBD1:CL4 Interface.校正剂VX-809与人囊性纤维化跨膜传导调节因子核苷酸结合结构域1的直接结合:结合位点与核苷酸结合结构域1:CL4界面之间变构偶联的证据
Mol Pharmacol. 2017 Aug;92(2):124-135. doi: 10.1124/mol.117.108373. Epub 2017 May 25.
6
Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR.鲁马卡托/依伐卡托治疗F508del-CFTR杂合型囊性纤维化患者
Ann Am Thorac Soc. 2017 Feb;14(2):213-219. doi: 10.1513/AnnalsATS.201609-689OC.
7
RNF5, DAB2 and Friends: Novel Drug Targets for Cystic Fibrosis.RNF5、DAB2 及相关蛋白:囊性纤维化的新型药物靶点
Curr Pharm Des. 2017;23(1):176-186. doi: 10.2174/1381612822666161006161033.
8
Cystic fibrosis: a clinical view.囊性纤维化:临床视角
Cell Mol Life Sci. 2017 Jan;74(1):129-140. doi: 10.1007/s00018-016-2393-9. Epub 2016 Oct 5.
9
New and emerging targeted therapies for cystic fibrosis.囊性纤维化的新型及新兴靶向疗法。
BMJ. 2016 Mar 30;352:i859. doi: 10.1136/bmj.i859.
10
Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation.泛素连接酶Rnf5的基因抑制减弱了与F508del囊性纤维化突变相关的表型。
Sci Rep. 2015 Jul 17;5:12138. doi: 10.1038/srep12138.